Dijiong Wu

27PUBLICATIONS
38CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyHaematologyIntensive care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Aug 26, 2026
Favorable response to second-line sirolimus regardless of STAT3/5b status in acquired pure red cell aplasia: A retrospective study from a single center.

|May 21, 2026
Current Knowledge of Immune Checkpoint Inhibitor-Induced Thrombocytopenia: Epidemiology, Mechanisms, and Management.

|Apr 21, 2026
HDAC8 inhibition targets STAT3-MYC axis and synergizes with Venetoclax in KMT2A-rearranged acute myeloid leukemia.

|Mar 17, 2026
Cord blood transfusion added matched unrelated donor transplantation as a preferable choice for aplastic anaemia: a comparative study from a single centre.

Tonglin Hu, Xinru Jia, Chuanao Xin

|Mar 11, 2026
Myeloid-Derived Suppressor Cells: Immunoregulatory Roles and Therapeutic Prospects in Immune-Mediated Hematological Disorders.

Qi Liu, Kunpeng Zhang, Shun He

|Jan 19, 2026
Peripheral versus Marrow Lipidomics in Patients with Severe Aplastic Anemia: Potential Indicators for Early Immunosuppressive Treatment Response.

Zexing Sun, Yilei Hong, Yaonan Hong

Pageof 5

Frequent Collaborators

9 joint publications

Baodong Ye

7 joint publications

Yingying Shen

4 joint publications

Qi Liu

3 joint publications

Hangping Ge